She was identified as having pregnancy induced hypertension and was treated with bed rest.
She also received a course of betamethasone.
She was evaluated in the labor and delivery suite and on [**2117-12-4**], was taken to Cesarean section under general anesthesia for known breech presentation and worsening pregnancy induced hypertension.
He required facial CPAP, positive pressure ventilation and intubation.
He was admitted to the NICU for treatment of prematurity.
At the time of delivery, the mother's hepatitis B surface antigen negative status was unknown and the infant was treated with hepatitis B vaccine and hepatitis B immunoglobulin.
He continued on continuous positive airway pressure     until day of life #27, [**2117-12-31**] when he transitioned     to high flow nasal cannula.
He is     being treated for apnea of prematurity with caffeine with     rare occasional spells.
Fluids, electrolytes and nutrition:  This infant     initially had an umbilical venous catheter for the first     week of life and then had a percutaneously inserted     central catheter for nutritional support.
and maintained on IV fluids.
At the time of discharge, he is     taking expressed breast milk 150 mL/kg/day, fortified to 30     cals per ounce with 4 calories of human milk fortifier, 4     calories of medium chain triglyceride oil, 2 calories of     Polycose and [**2-2**] tsp of BeneProtein powder per 100 ml of     breast milk.
Infant is receiving supplemental Vitamin E.     Nutrition labs on [**1-1**] showed Ca 9.9, Phos 5.2, Alk Phos 468.
A blood culture was obtained prior     to starting IV ampicillin and gentamycin.
He was treated with phototherapy for     approximately 96 hours.
Most recent eye examination on     [**2118-1-10**] showed mild worsening, with stage I, zone 2 ROP     in both eyes, 3 clock hours on the left and 5 clock hours on     the right with an added notation of a hemorrhage at 9     o'clock.
Feeding:  150 ml per kg per day of breast milk fortified     to 30 calories per ounce, 4 by human milk fortifier     powder, 4 by medium chain triglyceride oil, 2 calories     by Polycose and [**2-2**] tsp of BeneProtein powder per 100 ml     of breast milk.
Medications: Caffeine citrate 8.6 mg p.g.
Ferrous sulfate 2 mg per kg per day as a 25 mg/ml solution, 0.1 ml p.o.
Vitamin E 5 units p.g.
Hepatitis B vaccine and hepatitis B immunoglobulin were     administered on [**2117-12-4**].
Immunizations recommended: Synagis RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the following four criteria:  (1) Born at less than 32 weeks; (2) Born between 32 weeks and 35 weeks with two of the following:  Day care during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities or school age siblings; (3) chronic lung disease or (4) hemodynamically significant congenital heart disease.
Influenza immunization is recommended annually in the Fall for all infants once they reach 6 months of age.
Before this age, and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out-of-home caregivers.
This infant has not received rotavirus vaccine.
